Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:12 PM
Ignite Modification Date: 2025-12-25 @ 12:00 PM
NCT ID: NCT00798161
Term: Thrombocytopenia
Organ System: Blood and lymphatic system disorders
Assessment Type: None
Source Vocabulary: None
Notes: None
Study: NCT00798161
Study Brief: Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 72 View
EG001 None 1 144 View
EG002 None 0 147 View
EG003 None 0 142 View
EG004 None 0 143 View
EG005 None 0 143 View
EG006 None 0 66 View